Literature DB >> 22459237

Prevalence of bacteria in the circulation of cardiovascular disease patients, Madurai, India.

Vasudevan Dinakaran1, Leishman John, Andiappan Rathinavel, Paramasamy Gunasekaran, Jeyaprakash Rajendhran.   

Abstract

Cardiovascular diseases (CVDs) have a complex aetiology determined by risk factors, which include genetic and environmental factors. Chronic infection and inflammation is reported to be a pathogenic determinant for the development of CVDs. Here, we report the prevalence of bacterial pathogens in the circulation of CVD patients in Madurai, India. Blood culturing was performed using BD BACTEC automated culture system and organisms were identified by16S rRNA gene sequence analysis. From a total of 133 samples screened, 47 samples showed culture positive which indicates a high level of bacteraemia in CVD patients. From the 47 samples that showed growth, we have identified 57 bacterial isolates comprising 35 different species. Coagulase negative Staphylococci (CoNS) was the most predominant group of bacteria and other notable bacterial species isolated in this study are discussed.
Copyright © 2012 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22459237     DOI: 10.1016/j.hlc.2012.02.007

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  5 in total

1.  Genome sequence of Staphylococcus arlettae strain CVD059, isolated from the blood of a cardiovascular disease patient.

Authors:  Vasudevan Dinakaran; Manoharan Shankar; Sathyanarayanan Jayashree; Andiappan Rathinavel; Paramasamy Gunasekaran; Jeyaprakash Rajendhran
Journal:  J Bacteriol       Date:  2012-12       Impact factor: 3.490

2.  Endocytosis‒Mediated Invasion and Pathogenicity of Streptococcus agalactiae in Rat Cardiomyocyte (H9C2).

Authors:  Sharma Pooja; Muthuirulan Pushpanathan; Paramasamy Gunasekaran; Jeyaprakash Rajendhran
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

Review 3.  Exploring blood microbial communities and their influence on human cardiovascular disease.

Authors:  Ikram Khan; Imran Khan; Zhou Jianye; Zhang Xiaohua; Murad Khan; Mian Gul Hilal; Mian Adnan Kakakhel; Arshad Mehmood; An Lizhe; Li Zhiqiang
Journal:  J Clin Lab Anal       Date:  2022-03-15       Impact factor: 2.352

Review 4.  The role and mechanisms of gut microbiota in diabetic nephropathy, diabetic retinopathy and cardiovascular diseases.

Authors:  Qiulan Lv; Zhiyuan Li; Aihua Sui; Xiaomin Yang; Yafei Han; Ruyong Yao
Journal:  Front Microbiol       Date:  2022-08-18       Impact factor: 6.064

Review 5.  Gut microbes in cardiovascular diseases and their potential therapeutic applications.

Authors:  Ling Jin; Xiaoming Shi; Jing Yang; Yangyu Zhao; Lixiang Xue; Li Xu; Jun Cai
Journal:  Protein Cell       Date:  2020-09-28       Impact factor: 14.870

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.